The number of coronavirus cases recorded around the world has now climbed to 28.06 million, according to the Johns Hopkins University tracker. Deaths from the virus stand at 908,257. However, over 18.92 million people have been recovered from the virus.
Here are the top 10 global developments this morning:
1. France recorded almost 10,000 new Covid-19 infections on Thursday, its highest-ever single-day total.
2. New Zealand has recorded just one new community case of COVID-19 in on Thursday.
3. One therapeutic – dexamethasone – has already proven effective for patients with severe and critical COVID-19, others have been proven ineffective and still others are in trials. Around 180 vaccines are in development, including 35 in human trials: Tedros Adhanom Ghebreyesus, DG, WHO
4. Brazil recorded 40,557 additional confirmed cases of the coronavirus in the past 24 hours, and 983 deaths from the disease, the health ministry said on Thursday.
5. The United Nations has called for an immediate ‘quantum leap’ in funding for global programmes developing coronavirus treatments and vaccine candidates. A $15bn funding gap needs to be plugged over the next three months, the UN secretary-general said.
6. South Korea reported 176 new cases of Covid-19 on Thursday, bringing the total number of infections to 21,919, with 350 deaths, according to the Korea Center for Disease Control and Prevention (KCDC).
7. Greece has reported 372 new cases of the coronavirus, its highest daily figure since the pandemic began, bringing its total caseload to 12,452. Another four deaths were registered, taking the toll to 297.
8. India has recorded the highest single-day spike of 96,551 new cases and 1,209 deaths reported in the last 24 hours. The country’s tally has now crossed 45-lakh mark on Friday.
9. Germany has recorded 1,484 new cases of coronavirus, taking the total of confirmed cases in the country to 2567,850, and 9,342 deaths.
10. AstraZeneca’s coronavirus vaccine could still be available by the end of the year, or early next year, according to the company’s chief executive, Pascal Soriot, despite clinical trials being paused after a volunteer fell ill, The Guardian.